drugset / Trial / NCT06225323

Effect of Lidocaine Infusion on Neuraxial Opioid-induced Pruritus After Cesarean Section

NCT06225323 ↗

Completed 136 enrolled Aswan University
RandomizedParallel-groupDouble-blindPrevention

Summary

The aim of this study is to assess the efficacy and potency of lidocaine infusion as a preventive measure on pruritus response after injection of 200 micro gram morphine with bupivacaine subarachnoid block, spinal anesthesia, in cesarean section.

Timeline

Start
2024-01-29
Primary completion
2024-04-30
Completion
2024-04-30

Outcome

Met primary endpoint

paper Pruritus occurred in 36.2% receiving lidocaine vs 73.1% in the control group PMID 41370909 ↗

paper Intravenous lidocaine infusion reduced the incidence and early severity of neuraxial morphine-induced pruritus after cesarean delivery without increased adverse events. PMID 41370909 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 1.5 mg/kg Intravenous

Indications

No indication recorded.